Update on once-daily zonisamide monotherapy in partial seizures.

Abstract:

:Zonisamide is an antiepileptic drug that is structurally different from other antiepileptic agents. Its long half-life, once-daily dosing, lack of induction of hepatic enzymes, and broad spectrum of action makes it a suitable candidate for monotherapy. It has been approved as monotherapy for partial onset epilepsy in Japan and South Korea for more than a decade, and was recently approved as monotherapy in Europe. In the USA, it is only approved by the US Food and Drug Administration for adjunctive treatment of partial onset epilepsy. In this paper, we briefly review the literature on zonisamide monotherapy in partial onset epilepsy with regard to its efficacy, safety, tolerability, and long-term side effects, including a recent noninferiority trial in comparison with extended-release carbamazepine. While European regulatory agencies use noninferiority trials for approval of monotherapy, such a trial design does not meet the current regulatory requirements for approval as monotherapy in the USA.

authors

Afra P,Adamolekun B

doi

10.2147/NDT.S39152

subject

Has Abstract

pub_date

2014-03-19 00:00:00

pages

493-8

eissn

1176-6328

issn

1178-2021

pii

ndt-10-493

journal_volume

10

pub_type

杂志文章,评审
  • Clinical features and imaging findings in a case of Capgras syndrome.

    abstract::Capgras syndrome consists of the delusional belief that a person or persons have been replaced by doubles or impostors. It can occur in the context of both psychiatric and organic illness, and seems to be related to lesions of the bifrontal and right limbic and temporal regions. Indeed, magnetic resonance imaging has ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S47293

    authors: Luca M,Bordone A,Luca A,Patti A,Sortino G,Calandra C

    更新日期:2013-01-01 00:00:00

  • Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study.

    abstract::Cognitive impairment is closely related to real-life functioning in patients with schizophrenia. The aim of the present study was to evaluate the effects of adjunctive treatment with donepezil on cognition in patients with chronic schizophrenia. This was a 12-week, double-blind, randomized, placebo-controlled study of...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S64189

    authors: Zhu W,Zhang Z,Qi J,Liu F,Chen J,Zhao J,Guo X

    更新日期:2014-07-14 00:00:00

  • Screening for cognitive decline following single known stroke using the Mini-Mental State Examination.

    abstract:BACKGROUND:Progressive cognitive decline develops in a nontrivial minority of stroke survivors. Although commonly used to identify cognitive decline in older stroke survivors, the usefulness of the Mini-Mental State Examination (MMSE) as a screening tool for post-stroke cognitive decline across a wider range of ages is...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S17886

    authors: Arciniegas DB,Kellermeyer GF,Bonifer NM,Anderson-Salvi KM,Anderson CA

    更新日期:2011-01-01 00:00:00

  • Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

    abstract:Purpose:This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine. Methods:Twenty-four-hour activity patterns were compared across 5 days of 24-hour acti...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S172089

    authors: Duncan WC Jr,Slonena EE,Hejazi NS,Brutsche N,Park LT,Henter ID,Ballard ED,Zarate CA Jr

    更新日期:2018-10-16 00:00:00

  • Measuring cortisol and DHEA in fingernails: a pilot study.

    abstract:PURPOSE:Abnormalities in both cortisol and dehydroepiandrosterone (DHEA) have been reported in psychiatric disorders. Analysis of saliva, urine and blood cortisol and DHEA levels provides an index of hormone levels over a short time period. Unlike such conventional measures, fingernails incorporate endogenous hormones ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Warnock F,McElwee K,Seo RJ,McIsaac S,Seim D,Ramirez-Aponte T,Macritchie KA,Young AH

    更新日期:2010-02-03 00:00:00

  • Anxiety and depression in patients with head and neck cancer: 6-month follow-up study.

    abstract:OBJECTIVE:We aimed to assess psychiatric morbidities of patients with head and neck cancer (HNC) in a prospective study at pretreatment, and 3 and 6 months after treatment, and to compare their health-related quality of life (HRQL) between those with and without depressive disorders (depression). MATERIALS AND METHODS...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S103203

    authors: Wu YS,Lin PY,Chien CY,Fang FM,Chiu NM,Hung CF,Lee Y,Chong MY

    更新日期:2016-04-27 00:00:00

  • Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?

    abstract:BACKGROUND:Decreased relapse rate and slower disease progression have been reported with long-term use of immunomodulatory treatments (IMTs, interferon beta or glatiramer acetate) in relapsing-remitting multiple sclerosis. There are, however, patients who do not respond to such treatments, and they can be potential can...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S36771

    authors: Mezei Z,Bereczki D,Racz L,Csiba L,Csepany T

    更新日期:2012-01-01 00:00:00

  • Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy.

    abstract:Objective:To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists' judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. Methods:This was a prospective, observational, 12-week study in patients who received duloxetin...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S195445

    authors: Kuga A,Otsubo T,Tsuji T,Hayashi S,Imagawa H,Fujikoshi S,Escobar R

    更新日期:2019-04-05 00:00:00

  • Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.

    abstract:INTRODUCTION:Hemostasis is affected by interactions between physiological processes, including those connected with the coagulation system, whose essence is converting fibrinogen into fibrin. The role of factor VIII (FVIII) consists in activating factor X, which directly participates in the generation of thrombin, whic...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S43461

    authors: Lasek-Bal A,Puz P,Kazibutowska Z

    更新日期:2013-01-01 00:00:00

  • Reversible global aphasia as a side effect of quetiapine: a case report and literature review.

    abstract::Quetiapine is an atypical antipsychotic agent which is also prescribed for delirium due to its anti-dopaminergic effects; aphasia is an unusual side effect associated with the drug. Here, we report the case of an 83-year-old woman who was prescribed quetiapine (50 mg per day) for delirium. Unexpected, global aphasia o...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S141273

    authors: Chien CF,Huang P,Hsieh SW

    更新日期:2017-08-28 00:00:00

  • Evaluation of BPPV with vertebral artery values.

    abstract:Objectives:The aim of this study was to investigate the association between benign paroxysmal positional vertigo (BPPV) and vertebral artery (VA) flow rates and diameters by using Doppler ultrasonography in patients with BPPV. Additionally, we aimed to investigate the abnormalities of VA values obtained by extracranial...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S169991

    authors: Yazıcı A,İnanç Y

    更新日期:2018-08-06 00:00:00

  • A modification of intraluminal middle cerebral artery occlusion/reperfusion model for ischemic stroke with laser Doppler flowmetry guidance in mice.

    abstract::Stroke is one of the common causes of death and disability in the world. The intraluminal middle cerebral artery occlusion/reperfusion (MCAO/R) model is a "gold standard" in surgical ischemic stroke models. Here, we optimized the procedure of this model by ligating on external carotid artery (ECA) stump and two ligatu...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S118531

    authors: Cai Q,Xu G,Liu J,Wang L,Deng G,Liu J,Chen Z

    更新日期:2016-11-03 00:00:00

  • Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan.

    abstract:Introduction:Sleep disturbance is a major health concern for heroin users receiving methadone maintenance treatment (MMT). The present study was aimed to investigate the predictors for new-onset clinically predominant sleep disturbance (CPSD) among heroin users receiving MMT. Methods:This 2-year retrospective study in...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S177370

    authors: Li DJ,Chung KS,Wu HC,Hsu CY,Yen CF

    更新日期:2018-10-26 00:00:00

  • Effect of low-energy extracorporeal shock wave on vascular regeneration after spinal cord injury and the recovery of motor function.

    abstract:BACKGROUND:Latest studies show that low-energy extracorporeal shock wave therapy (ESWT) can upregulate levels of vascular endothelial growth factor (VEGF). VEGF can ease nervous tissue harm after spinal cord injury (SCI). This study aims to explore whether low-energy ESWT can promote expression of VEGF, protect nervous...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,收录出版

    doi:10.2147/NDT.S82864

    authors: Wang L,Jiang Y,Jiang Z,Han L

    更新日期:2016-08-31 00:00:00

  • A family-oriented therapy program for youths with substance abuse: long-term outcomes related to relapse and academic or social status.

    abstract:OBJECTIVE:The abuse of illegal substances by youths in Taiwan has become a major public health issue. This study explores the outcomes (relapse rate and academic or social status) of a family-oriented therapy program conducted for substance-using youths who were referred by a judge to participate in it. METHODS:The pr...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S105199

    authors: Wang LJ,Lu SF,Chong MY,Chou WJ,Hsieh YL,Tsai TN,Chen C,Lee YH

    更新日期:2016-03-30 00:00:00

  • Bridging the Gap Between Physical Health and Autism Spectrum Disorder.

    abstract::Autism spectrum disorder (ASD) is a highly complex and heterogeneous developmental disorder that affects how individuals communicate with other people and relate to the world around them. Research and clinical focus on the behavioural and cognitive manifestations of ASD, whilst important, have obscured the recognition...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S251394

    authors: Sala R,Amet L,Blagojevic-Stokic N,Shattock P,Whiteley P

    更新日期:2020-06-30 00:00:00

  • Brain activity modification produced by a single radioelectric asymmetric brain stimulation pulse: a new tool for neuropsychiatric treatments. Preliminary fMRI study.

    abstract:PURPOSE:Radioelectric asymmetric brain stimulation technology with its treatment protocols has shown efficacy in various psychiatric disorders. The aim of this work was to highlight the mechanisms by which these positive effects are achieved. The current study was conducted to determine whether a single 500-millisecond...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S26123

    authors: Rinaldi S,Fontani V,Castagna A

    更新日期:2011-01-01 00:00:00

  • The use of natalizumab for multiple sclerosis.

    abstract::Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte trafficking into the central nervous system. It is US Food and Drug Administration (FDA) approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Natalizumab demonstrated high efficacy in Phase III tria...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S114636

    authors: Brandstadter R,Katz Sand I

    更新日期:2017-06-28 00:00:00

  • Review: management of Parkinson's disease.

    abstract::Parkinson's disease (PD) is one of the most frequent neurological diseases. Despite the modern imaging and nuclear techniques which help to diagnose it in a very early stage and lead to a better discrimination of similar diseases, PD has remained a clinical diagnosis. The increasing number of available treatment optio...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S32302

    authors: Pedrosa DJ,Timmermann L

    更新日期:2013-01-01 00:00:00

  • Transcranial magnetic stimulation for treating depression in elderly patients.

    abstract:PURPOSE:The aim of the study reported here was to examine the safety and effectiveness of high-frequency repetitive transcranial magnetic stimulation (rTMS) in elderly patients with depression. PATIENTS AND METHODS:Sixty-five depressed elderly patients received rTMS over their left prefrontal cortex for 6 days per wee...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S44241

    authors: Hizli Sayar G,Ozten E,Tan O,Tarhan N

    更新日期:2013-01-01 00:00:00

  • Towards an Outpatient Model of Care for Motor Functional Neurological Disorders: A Neuropsychiatric Perspective.

    abstract::Functional neurological disorder (FND), a condition at the intersection of neurology and psychiatry, is a common and disabling outpatient referral to neurology and neuropsychiatry clinics. In this perspective article, we focus on the motor spectrum of FND (mFND), including individuals with functional movement disorder...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S247119

    authors: Saxena A,Godena E,Maggio J,Perez DL

    更新日期:2020-09-18 00:00:00

  • Psychiatric comorbidities in patients with intentional methanol intoxication.

    abstract:Background:Intentional methanol intoxication (IMI) is an emerging public health issue in Asian countries, but few data are available in the literature on underlying psychiatric comorbidities in these suicide attempters. Patients and methods:We conducted a retrospective chart review on patients with methanol intoxicati...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S192943

    authors: Yang WS,Yen TH,Juang YY,Lee SH,Wang BH,Lee CP

    更新日期:2019-01-31 00:00:00

  • Gene-Environment Interactions in Major Mental Disorders in the Czech Republic.

    abstract:Background:Mental disorders affect about one-third of the human population, are typically chronic and significantly decrease the quality of life. Presently, the treatment of mental illnesses is far from adequate with a substantial proportion of the patients being pharmacoresistant and suffering from relapses. One of t...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S238522

    authors: Latalova K,Sery O,Hosakova K,Hosak L

    更新日期:2020-05-06 00:00:00

  • Mycophenolate mofetil for myasthenia gravis: a clear and present controversy.

    abstract::Mycophenolate mofetil (MMF) has been used to treat myasthenia gravis (MG) for over 10 years. MMF's use in the MG population stems from its theoretical mechanism of action and the medical literature that supports its benefit in MG patients. Recently, two large, double-blinded, placebo-controlled, randomized clinical tr...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s3309

    authors: Heatwole C,Ciafaloni E

    更新日期:2008-12-01 00:00:00

  • The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder.

    abstract:OBJECTIVES:This article addresses the clinical role for ziprasidone used adjunctively with a mood stabilizer in maintenance treatment of bipolar disorder. This review also addresses the strengths and limitations of design features in adjunctive studies of second-generation antipsychotic drugs added to mood stabilizers....

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S9932

    authors: Bowden CL

    更新日期:2011-01-01 00:00:00

  • Towards Horizon 2020: challenges and advances for clinical mental health research - outcome of an expert survey.

    abstract:BACKGROUND:The size and increasing burden of disease due to mental disorders in Europe poses substantial challenges to its population and to the health policy of the European Union. This warrants a specific research agenda concerning clinical mental health research as one of the cornerstones of sustainable mental healt...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S59958

    authors: van der Feltz-Cornelis CM,van Os J,Knappe S,Schumann G,Vieta E,Wittchen HU,Lewis SW,Elfeddali I,Wahlbeck K,Linszen D,Obradors-Tarragó C,Haro JM

    更新日期:2014-06-27 00:00:00

  • Corpus callosum infarction with cognitive dysfunction: two case reports and literature review.

    abstract:Introduction:The incidence of corpus callosum infarction is low, and sudden cognitive dysfunction caused by corpus callosum infarction is very rare. We report two cases of acute corpus callosum infarction with sudden cognitive impairment, and the related basis, clinical manifestations, diagnosis, differential diagnosis...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S155487

    authors: Zhang J,Tang Y,Sun Y,Xu Y,Pang L,Li J,Wu T,He M

    更新日期:2018-02-13 00:00:00

  • The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National Surve

    abstract:Background:Suicidal ideation (SI) is a cardinal aspect of major depressive disorder (MDD); however, patient-reported outcomes data from large-scale surveys are limited concerning SI in the context of MDD. This study aims to understand the association between varying levels of SI and health-related quality of life (HRQo...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S229530

    authors: Benson C,Singer D,Carpinella CM,Shawi M,Alphs L

    更新日期:2021-01-18 00:00:00

  • Brain regions associated with anosognosia for memory disturbance in Alzheimer's disease: a magnetic resonance imaging study.

    abstract:BACKGROUND AND OBJECTIVE:Patients with Alzheimer's disease (AD) are frequently unaware of their cognitive symptoms and medical diagnosis. The term "anosognosia" is used to indicate a general lack of awareness of one's disease or disorder. The neural substrate underlying anosognosia in AD is unclear. Since anosognosia f...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S139177

    authors: Fujimoto H,Matsuoka T,Kato Y,Shibata K,Nakamura K,Yamada K,Narumoto J

    更新日期:2017-07-05 00:00:00

  • Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice.

    abstract:BACKGROUND:Oral cholinesterase inhibitors at doses efficacious for the treatment of Alzheimer's disease (AD) are often prematurely discontinued due to gastrointestinal side effects. In controlled clinical trials, transdermal rivastigmine demonstrated less such effects at similar efficacy. The current study aimed to ver...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S29116

    authors: Seibert J,Tracik F,Articus K,Spittler S

    更新日期:2012-01-01 00:00:00